During H1FY17, Aconex Ltd reported a revenue growth of 38% yoy to $77.0 million, primarily driven by the acquisition of Conject Holding GmbH in March 2016 and strong international growth. Earnings before interest, taxes, depreciation, and amortization (EBITDA) from core operations, excluding acquisition and integration costs grew by 9% yoy to $7.4 million. The company’s cash and cash equivalents stood
Read more
NextDC Ltd has completed the subscription of $300 million senior unsecured, 6.25% fixed rate debt offering (Notes III). Subscription for Notes III included a combination of new investor funds and the discretionary rollover of selected Notes I and Notes II securities. NXT will use the net cash proceeds of Notes III to redeem the balance of the remaining Notes I
Read more
NextDC Ltd has completed the subscription of $300 million senior unsecured, 6.25% fixed rate debt offering (Notes III). Subscription for Notes III included a combination of new investor funds and the discretionary rollover of selected Notes I and Notes II securities. NXT will use the net cash proceeds of Notes III to redeem the balance of the remaining Notes I
Read more
Favorable regulatory developments: Recently, the Australian government has announced changes to existing medical practitioner’s norms by increasing the ability of Australian medical practitioners to prescribe cannabinoid medicines to critically ill patients. The Therapeutic Goods Administration (TGA) currently has two access pathways in which Australian medical practitioners may prescribe unregistered cannabinoid medicines, the Authorised Prescriber Scheme (APS) and the Special Access
Read more
Reiterated FY17 guidance: Shares of Sirtex Medical Limited (ASX: SRX) zoomed 16.16%, after the announcement of its full year guidance for FY17 and write down of R&D assets. SRX expects 5.5% yoy overall growth in worldwide dose sales at approximately 12,590 and underlying EBITDA of $72 million for FY17. Further, across the three regions, it estimates 4.7% yoy growth in
Read more
The Blackmores Limited (ASX: BKL) share price has dropped 4.4% to $89.81, following the resignation of its CEO Christine Holgate. The company has announced that Chief Executive Officer and Managing Director Christine Holgate will leave Blackmores on 29 September 2017, after nine years of stint at the Australia’s leading natural healthcare company. Further, the board has asked Director Marcus Blackmore
Read more
Link Administration Holdings (ASX: LNK) has entered into a binding agreement to acquire Capita Asset Services (CAS) from Capita plc (Capita) for £888 million (~A$1,493 million). The Acquisition is subject to mandatory regulatory approvals and is expected to complete by 31 December 2017. CAS is an established player in providing a range of financial and administrative services in the UK
Read more